Table 3.

Relationship between miR-497 and different parameters in hepatocellular carcinoma cases (n = 60).

	N	miR-497		Test of Significance	p-Value
		Min.–Max.	Mean ± SD.
Gender
Male	36	0.3–1.2	0.8 ± 0.3	t = 1.884	0.070
Female	24	0.3–2.2	1.1 ± 0.7
Family history
No	45	0.3–2.1	0.8 ± 0.4	t = 1.407	0.178
Yes	15	0.3–2.2	1.1 ± 0.7
Smoking
No	15	0.3–2.2	1.0 ± 0.6	t = 0.748	0.457
Yes	45	0.3–2.2	0.9 ± 0.5
HCV ab
Negative	18	0.3–2.2	1 ± 0.6	t = 0.768	0.446
Positive	42	0.4–2.2	0.9 ± 0.4
HBs Ag
Negative	40	0.3–2.2	1.0 ± 0.5	t = 3.224 *	0.002 *
Positive	20	0.3–1.1	0.7 ± 0.2
Tumor number
≤2	52	0.3–2.2	1.0 ± 0.5	t = 2.250 *	0.028 *
>2	8	0.3–0.9	0.6 ± 0.2
Tumor size
≤5 cm	37	0.3–2.2	1.0 ± 0.5	t = 2.358 *	0.022 *
>5 cm	23	0.3–2.2	0.7 ± 0.4
LN metastasis
N0	52	0.3–2.2	1.0 ± 0.5	t = 3.079 *	0.003 *
N1	8	0.3–0.7	0.4 ± 0.1
Distant metastasis
M0	52	0.3–2.2	1.0 ± 0.5	t = 3.079 *	0.003 *
M1	8	0.3–0.7	0.4 ± 0.1
Vascular invasion
No	20	0.3–2.2	1.1 ± 0.5	t = 2.105 *	0.040 *
Yes	40	0.3–2.2	0.8 ± 0.4
Child–Pugh score
A	41	0.3–2.2	1 ± 0.6	t = 2.013 *	0.049 *
B	19	0.4–1.1	0.8 ± 0.2
BCLC staging
0–A	43	0.3–2.2	1.0 ± 0.5	F = 3.322 *	0.043 *
B	12	0.3–1.1	0.8 ± 0.2
C	5	0.3–0.7	0.5 ± 0.2

t: Student t-test. F: ANOVA test. *: Statistically significant at p-value ≤ 0.05.